{"title":"Investigating Connectivity Deficits in Alzheimer's Disease Using a Novel 3D Bioprinted Model Designed to Quantify Neurite Outgrowth.","authors":"Chloe Whitehouse, Ellie Bravington, Anirudh Patir, Wei Wei, Janet Brownlees, Yufang He, Nicola Corbett","doi":"10.3390/bioengineering12030245","DOIUrl":null,"url":null,"abstract":"<p><p>Here, we present a novel 3D bioprinted model of the forebrain cortex designed to quantify neurite outgrowth across a hydrogel bridge. To validate this model, we cultured Alzheimer's disease (AD) forebrain cortical populations derived from human iPSCs carrying APP (amyloid precursor protein) mutations (K670M/N671L + V717F). Neurite and synapse formation were significantly impaired in 3D AD mutant cultures compared to controls, but this was not replicated in 2D, highlighting deficits in these traditional 2D cell culture models. To investigate the mechanisms underlying impaired neurite outgrowth in 3D and 2D models of AD, we assessed amyloid-β dysfunction, mitochondrial health, and oxidative stress in both conditions. In the 3D model, APP mutant cultures exhibited reduced mitochondrial membrane potential and fragmented networks, indicating dysfunction and potential cellular energy deficits. Additionally, elevated oxidative stress and proteostasis disruption were identified in the 3D AD models as indicators of cellular damage, which may be limiting neurite extension. Furthermore, transcriptomic (bulk RNA-Seq) analysis revealed distinct differences in gene expression pathways between 2D and 3D models of AD, suggesting alternate underlying mechanisms of disease pathology between the culture conditions. This study demonstrates the functionality of this novel 3D bioprinted model for quantifying neurite connectivity and identifying underlying disease mechanisms.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 3","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11939190/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12030245","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Here, we present a novel 3D bioprinted model of the forebrain cortex designed to quantify neurite outgrowth across a hydrogel bridge. To validate this model, we cultured Alzheimer's disease (AD) forebrain cortical populations derived from human iPSCs carrying APP (amyloid precursor protein) mutations (K670M/N671L + V717F). Neurite and synapse formation were significantly impaired in 3D AD mutant cultures compared to controls, but this was not replicated in 2D, highlighting deficits in these traditional 2D cell culture models. To investigate the mechanisms underlying impaired neurite outgrowth in 3D and 2D models of AD, we assessed amyloid-β dysfunction, mitochondrial health, and oxidative stress in both conditions. In the 3D model, APP mutant cultures exhibited reduced mitochondrial membrane potential and fragmented networks, indicating dysfunction and potential cellular energy deficits. Additionally, elevated oxidative stress and proteostasis disruption were identified in the 3D AD models as indicators of cellular damage, which may be limiting neurite extension. Furthermore, transcriptomic (bulk RNA-Seq) analysis revealed distinct differences in gene expression pathways between 2D and 3D models of AD, suggesting alternate underlying mechanisms of disease pathology between the culture conditions. This study demonstrates the functionality of this novel 3D bioprinted model for quantifying neurite connectivity and identifying underlying disease mechanisms.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering